Endometriosis-related ovarian cancer: where are we now? A narrative review towards a pragmatic approach

G Centini, G Schettini, E Pieri, M Giorgi… - Journal of clinical …, 2024 - mdpi.com
Background: Endometriosis affects more than 10% of reproductive-aged women, causing
pelvic pain and infertility. Despite the benign nature of endometriosis, ovarian …

The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects

PB Clement - Advances in anatomic pathology, 2007 - journals.lww.com
Although the histologic diagnosis of endometriosis is usually straightforward, many
diagnostic problems can arise as a result of alterations or absence of its glandular or stromal …

[HTML][HTML] Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management

HT Lynch, MJ Casey, CL Snyder, C Bewtra, JF Lynch… - Molecular …, 2009 - Elsevier
Hereditary ovarian cancer accounts for at least 5% of the estimated 22,000 new cases of this
disease during 2009. During this same time, over 15,000 will die from malignancy ascribed …

Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects

JJ Wei, J William, S Bulun - International Journal of Gynecological …, 2011 - journals.lww.com
Endometriosis is a chronic disease that affects millions of reproductive-age women. Despite
the destructive and invasive nature of endometrioses, most cases are perpetually benign or …

Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology

SW Guo - Human reproduction update, 2020 - academic.oup.com
BACKGROUND Endometriosis is a benign gynaecological disease. Thus, it came as a
complete surprise when it was reported recently that the majority of deep endometriosis …

[HTML][HTML] Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma

A Ayhan, TL Mao, T Seckin, CH Wu, B Guan… - International journal of …, 2012 - Elsevier
Objectives ARID1A is a recently identif ied tumor suppressor participating in chromatin
remodeling. Somatic inactivating mutations of ARID1A and loss of its expression occur …

Precursors and pathogenesis of ovarian carcinoma

D Lim, E Oliva - Pathology-Journal of the RCPA, 2013 - journals.lww.com
The ultimate goal of defining cancer specific precursors is to facilitate early detection and
intervention before the development of invasive malignancy. Unlike other malignancies …

Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development

A Dawson, ML Fernandez, M Anglesio… - …, 2018 - pmc.ncbi.nlm.nih.gov
Endometriosis is a fascinating disease that we strive to better understand. Molecular
techniques are shedding new light on many important aspects of this disease: from …

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

M Mandai, K Yamaguchi, N Matsumura, T Baba… - International journal of …, 2009 - Springer
Recent molecular and pathological evidence suggests that endometriosis is a monoclonal,
neoplastic disease. Moreover, endometriosis serves as a precursor of ovarian cancer …

Clear cell carcinoma of the ovary

K Fujiwara, K Oda, M Takano… - Textbook of Uncommon …, 2017 - Wiley Online Library
Clear cell carcinoma of the ovary is a distinct histological subtype of epithelial ovarian
cancer characterized by mutations in ARID1A and PIK3CA. These malignancies account for …